Biodexa Pharmaceuticals Plc

$BDRX is up over 100% and the leader of the Nasdaq after the company entered an agreement to acquire Adhera Therapeutics’s rights to tolimidone, a potential diabetes treatment

Share This Article

 

About the Author

Biodexa Pharmaceuticals Plc

Joey Ramson